PODCAST · health
Ozempic and Cancer Risk — What We Know
by Inception Point Ai
Dr. Ben Synth investigates whether GLP-1 drugs like Ozempic cause cancer or prevent it, untangling rodent studies, FDA warnings, and surprising evidence that these medications might actually protect against obesity-related tumors. Discover why the truth is far more nuanced than headlines suggest. For more content like this, visit QuietPlease.aiThis show includes AI-generated content.
-
4
Ozempic and Cancer Risk — Uncover what the science really says with Dr. Ben Synth
Join Dr. Ben Synth as he cuts through the clickbait to uncover the real science behind Ozempic and cancer risk. From misunderstood rat studies to unexpected protective effects, this series reveals why the truth is far more fascinating than the headlines. Subscribe now to separate fear from facts.Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTVThis content was created in partnership and with the help of Artificial Intelligence AIThis episode includes AI-generated content.
-
3
Ozempic and Cancer Risk — What We Know - The Detection Trap
Join host Ben Synth as we examine the "detection trap" — when heightened surveillance creates the illusion of drug danger. We explore why Ozempic's thyroid cancer warnings may reflect statistical artifacts rather than real risk, analyzing large-scale studies showing no significant increase. Learn how detection bias distorts medical headlines and reshapes cancer screening debates.Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTVThis content was created in partnership and with the help of Artificial Intelligence AIThis episode includes AI-generated content.
-
2
Ozempic and Cancer Risk — What We Know - The Cancer Shield Nobody Expected
AI host Ben Synth explores emerging research suggesting GLP-1 drugs like Ozempic may reduce cancer risk despite thyroid tumor warnings. Studies show potential 17-39% lower rates for obesity-related cancers including colon, endometrial, and ovarian. Episode examines metabolic mechanisms, observational study limitations, and why drugs designed for diabetes might unexpectedly shield against cancer.Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTVThis content was created in partnership and with the help of Artificial Intelligence AIThis episode includes AI-generated content.
-
1
Ozempic and Cancer Risk — What We Know - The Rat Trap
Join AI host Ben Synth as he explores the decades-long story behind Ozempic's black box thyroid cancer warning. Discover how rodent tumors from 1990s testing shaped today's prescription labels, why rat thyroid biology differs fundamentally from human biology, and what massive patient studies actually reveal about cancer risk versus emerging protective benefits.Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTVThis content was created in partnership and with the help of Artificial Intelligence AIThis episode includes AI-generated content.
We're indexing this podcast's transcripts for the first time — this can take a minute or two. We'll show results as soon as they're ready.
No matches for "" in this podcast's transcripts.
No topics indexed yet for this podcast.
Loading reviews...
ABOUT THIS SHOW
Dr. Ben Synth investigates whether GLP-1 drugs like Ozempic cause cancer or prevent it, untangling rodent studies, FDA warnings, and surprising evidence that these medications might actually protect against obesity-related tumors. Discover why the truth is far more nuanced than headlines suggest. For more content like this, visit QuietPlease.aiThis show includes AI-generated content.
HOSTED BY
Inception Point Ai
Loading similar podcasts...
Frequently Asked Questions
How many episodes does Ozempic and Cancer Risk — What We Know have?
Ozempic and Cancer Risk — What We Know currently has 4 episodes available on PodParley. New episodes are automatically indexed when they're published to the podcast feed.
What is Ozempic and Cancer Risk — What We Know about?
Dr. Ben Synth investigates whether GLP-1 drugs like Ozempic cause cancer or prevent it, untangling rodent studies, FDA warnings, and surprising evidence that these medications might actually protect against obesity-related tumors. Discover why the truth is far more nuanced than headlines suggest....
How often does Ozempic and Cancer Risk — What We Know release new episodes?
Ozempic and Cancer Risk — What We Know is no longer actively publishing new episodes, but the existing catalog remains available.
Where can I listen to Ozempic and Cancer Risk — What We Know?
You can listen to Ozempic and Cancer Risk — What We Know on PodParley by clicking any episode. We provide an embedded audio player for direct listening.
Who hosts Ozempic and Cancer Risk — What We Know?
Ozempic and Cancer Risk — What We Know is created and hosted by Inception Point Ai.
URL copied to clipboard!